News

Press Release

bit.bio unveils cell therapy pipeline, lead candidate and expanded SAB

Lead candidate is encapsulated allogeneic txHepatocytes for treatment of acute liver failure, SAB expanded to include 3 global experts in cell therapy.

08.11.2023

Published by bit.bio

Lead candidate is encapsulated allogeneic txHepatocytes for treatment of acute liver failure, SAB expanded to include 3 global experts in cell therapy.

Published by bit.bio

Read now

Press Release

Product launch | CRISPR-Ready ioGlutamatergic Neurons

bit.bio launches first product in groundbreaking ioCRISPR-Ready Cells™ product range, paving the way for new advances in disease m...

17.10.2023

Published by bit.bio

Read now

Article

bit.bio named as one of the WIRED Trailblazers in Cambridge

WIRED have named 16 Trailblazer companies in Cambridge that are pushing boundaries and scaling up - including bit.bio.

16.10.2023

Published by Wired

Read now

Article

Five things you need to succeed as a leader - Authority Magazine Q&A

Authority Magazine interviewed bit.bio's SVP of tech ops and manufacturing Kathryn Golden to discover her path to leadership and w...

16.10.2023

Published by Authority Magazine

Read now

Article

Navigating the future of cell therapies with exec Kathryn Corzo

Our President and COO Kathryn Corzo talks with editor Brian Buntz from Drug Discovery & Development.

30.08.2023

Published by Drug Discovery & Development

Read now

Press Release

Synthego and bit.bio expand strategic partnership

Partnership to build a platform for the development of safer and more efficient genetic engineering of human cells for cell therap...

24.08.2023

Published by bit.bio

Read now

New product

Disease model panel to advance Frontotemporal dementia drug discovery

New iPSC-derived opti-ox™ powered disease model cells with the potential to advance frontotemporal dementia research and drug disc...

23.08.2023

Published by bit.bio

Read now

News

We have achieved the Gold award from Green Impact

bit.bio received a gold award for its participation in the Green Impact awards for sustainability.

15.08.2023

Published by bit.bio

Read now

Press Release

BlueRock Therapeutics and bit.bio announce collaboration

BlueRock Therapeutics and bit.bio announce collaboration and option agreement for the discovery & manufacture of regulatory T cell...

03.08.2023

Published by bit.bio

Read now

Related pages